Sign in

CIK 0001160308

  • Non-accelerated filer
  • Smaller reporting company
Ticker
SVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841318182
Phone
+51 285113796
Business address
6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
Former names
Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
  1. 4 Grant or award Chief Medical Officer acquired 35,000 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market buy Director bought 48,225 shares at $2.04 ($98,572)
  4. 4 Open-market buy Director bought 10,000 shares at $2.08 ($20,825)
  5. 4 Open-market buy Director bought 150,000 shares at $2.78 ($416,250)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Shares withheld for taxes Chief Operating Officer gave up 38,263 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Business Officer gave up 18,263 shares (to pay taxes)
  9. 4 Grant or award Chief Commercial Officer acquired 20,000 shares (grant or award)
  10. 4 Grant or award Chief Operating Officer acquired 100,000 shares (grant or award)
  11. 4 Open-market sale Chief Financial Officer sold 25,000 shares at $3.33 ($83,278)
  12. 4 Grant or award Chief Medical Officer acquired 80,000 shares (grant or award)
  13. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 54,702 shares at $3.31 ($180,828)
  14. 4 Open-market sale Director sold 8,000 shares at $3.32 ($26,569)
  15. 4 Grant or award Director acquired 40,000 shares (grant or award)
  16. 4 Grant or award Director acquired 40,000 shares (grant or award)
  17. 4 Grant or award Director acquired 40,000 shares (grant or award)
  18. 4 Grant or award Director acquired 40,000 shares (grant or award)
  19. 4 Open-market buy Director bought 20,000 shares at $2.95 ($59,072)
  20. 4 Open-market buy Director bought 100,000 shares at $2.88 ($287,600)

Page 2 of 22 · 436 filings